1. Home
  2. CRL vs PSN Comparison

CRL vs PSN Comparison

Compare CRL & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • PSN
  • Stock Information
  • Founded
  • CRL 1947
  • PSN 1944
  • Country
  • CRL United States
  • PSN United States
  • Employees
  • CRL N/A
  • PSN N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • PSN EDP Services
  • Sector
  • CRL Health Care
  • PSN Technology
  • Exchange
  • CRL Nasdaq
  • PSN Nasdaq
  • Market Cap
  • CRL 9.8B
  • PSN 10.4B
  • IPO Year
  • CRL 2000
  • PSN 2019
  • Fundamental
  • Price
  • CRL $186.29
  • PSN $93.43
  • Analyst Decision
  • CRL Hold
  • PSN Strong Buy
  • Analyst Count
  • CRL 13
  • PSN 9
  • Target Price
  • CRL $211.64
  • PSN $105.78
  • AVG Volume (30 Days)
  • CRL 531.0K
  • PSN 833.5K
  • Earning Date
  • CRL 02-12-2025
  • PSN 02-12-2025
  • Dividend Yield
  • CRL N/A
  • PSN N/A
  • EPS Growth
  • CRL N/A
  • PSN N/A
  • EPS
  • CRL 8.00
  • PSN 0.72
  • Revenue
  • CRL $4,060,916,000.00
  • PSN $6,510,485,000.00
  • Revenue This Year
  • CRL N/A
  • PSN $25.71
  • Revenue Next Year
  • CRL $1.18
  • PSN $9.12
  • P/E Ratio
  • CRL $23.28
  • PSN $130.09
  • Revenue Growth
  • CRL N/A
  • PSN 28.88
  • 52 Week Low
  • CRL $176.48
  • PSN $61.36
  • 52 Week High
  • CRL $275.00
  • PSN $114.68
  • Technical
  • Relative Strength Index (RSI)
  • CRL 42.96
  • PSN 36.89
  • Support Level
  • CRL $180.21
  • PSN $93.93
  • Resistance Level
  • CRL $188.04
  • PSN $96.92
  • Average True Range (ATR)
  • CRL 6.14
  • PSN 2.37
  • MACD
  • CRL -1.04
  • PSN 0.01
  • Stochastic Oscillator
  • CRL 27.01
  • PSN 10.57

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: